REPORT ID 3285

Global Conjugate Vaccine Sales Market Report 2017

Publish Date
13-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the global Conjugate Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Conjugate Vaccine for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Conjugate Vaccine market competition by top manufacturers/players, with Conjugate Vaccine sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bharat Biotech (India)
    Biological E (India)
    CSL Limited (Australia)
    GlaxoSmithKline (U.K.)
    Merck and Company (U.S.)
    Neuron Biotech (U.S.)
    Novartis AG (Switzerland)
    Pfizer (U.S.)
    Sanofi Pasteur (France)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Disease Indication
        Pneumococcal
        Influenza
        Diphtheria Tetanus Pertussis
        Meningococcal
    By Type
        Monovalent
        Multivalen
    By Patient Stage
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Conjugate Vaccine Sales Market Report 2017
1 Conjugate Vaccine Market Overview
    1.1 Product Overview and Scope of Conjugate Vaccine
    1.2 Classification of Conjugate Vaccine by Product Category
        1.2.1 Global Conjugate Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Conjugate Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Pneumococcal
        1.2.4 Influenza
        1.2.5 Diphtheria Tetanus Pertussis
        1.2.6 Meningococcal
    1.3 Global Conjugate Vaccine Market by Application/End Users
        1.3.1 Global Conjugate Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Medical Center
    1.4 Global Conjugate Vaccine Market by Region
        1.4.1 Global Conjugate Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Conjugate Vaccine Status and Prospect (2012-2022)
        1.4.3 China Conjugate Vaccine Status and Prospect (2012-2022)
        1.4.4 Europe Conjugate Vaccine Status and Prospect (2012-2022)
        1.4.5 Japan Conjugate Vaccine Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Conjugate Vaccine Status and Prospect (2012-2022)
        1.4.7 India Conjugate Vaccine Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Conjugate Vaccine (2012-2022)
        1.5.1 Global Conjugate Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 Global Conjugate Vaccine Revenue and Growth Rate (2012-2022)

2 Global Conjugate Vaccine Competition by Players/Suppliers, Type and Application
     2.1 Global Conjugate Vaccine Market Competition by Players/Suppliers
        2.1.1 Global Conjugate Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Conjugate Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Conjugate Vaccine (Volume and Value) by Type
        2.2.1 Global Conjugate Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 Global Conjugate Vaccine Revenue and Market Share by Type (2012-2017)
    2.3 Global Conjugate Vaccine (Volume and Value) by Region
        2.3.1 Global Conjugate Vaccine Sales and Market Share by Region (2012-2017)
        2.3.2 Global Conjugate Vaccine Revenue and Market Share by Region (2012-2017)
    2.4 Global Conjugate Vaccine (Volume) by Application

3 United States Conjugate Vaccine (Volume, Value and Sales Price)
    3.1 United States Conjugate Vaccine Sales and Value (2012-2017)
        3.1.1 United States Conjugate Vaccine Sales and Growth Rate (2012-2017)
        3.1.2 United States Conjugate Vaccine Revenue and Growth Rate (2012-2017)
        3.1.3 United States Conjugate Vaccine Sales Price Trend (2012-2017)
    3.2 United States Conjugate Vaccine Sales Volume and Market Share by Players
    3.3 United States Conjugate Vaccine Sales Volume and Market Share by Type
    3.4 United States Conjugate Vaccine Sales Volume and Market Share by Application

4 China Conjugate Vaccine (Volume, Value and Sales Price)
    4.1 China Conjugate Vaccine Sales and Value (2012-2017)
        4.1.1 China Conjugate Vaccine Sales and Growth Rate (2012-2017)
        4.1.2 China Conjugate Vaccine Revenue and Growth Rate (2012-2017)
        4.1.3 China Conjugate Vaccine Sales Price Trend (2012-2017)
    4.2 China Conjugate Vaccine Sales Volume and Market Share by Players
    4.3 China Conjugate Vaccine Sales Volume and Market Share by Type
    4.4 China Conjugate Vaccine Sales Volume and Market Share by Application

5 Europe Conjugate Vaccine (Volume, Value and Sales Price)
    5.1 Europe Conjugate Vaccine Sales and Value (2012-2017)
        5.1.1 Europe Conjugate Vaccine Sales and Growth Rate (2012-2017)
        5.1.2 Europe Conjugate Vaccine Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Conjugate Vaccine Sales Price Trend (2012-2017)
    5.2 Europe Conjugate Vaccine Sales Volume and Market Share by Players
    5.3 Europe Conjugate Vaccine Sales Volume and Market Share by Type
    5.4 Europe Conjugate Vaccine Sales Volume and Market Share by Application

6 Japan Conjugate Vaccine (Volume, Value and Sales Price)
    6.1 Japan Conjugate Vaccine Sales and Value (2012-2017)
        6.1.1 Japan Conjugate Vaccine Sales and Growth Rate (2012-2017)
        6.1.2 Japan Conjugate Vaccine Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Conjugate Vaccine Sales Price Trend (2012-2017)
    6.2 Japan Conjugate Vaccine Sales Volume and Market Share by Players
    6.3 Japan Conjugate Vaccine Sales Volume and Market Share by Type
    6.4 Japan Conjugate Vaccine Sales Volume and Market Share by Application

7 Southeast Asia Conjugate Vaccine (Volume, Value and Sales Price)
    7.1 Southeast Asia Conjugate Vaccine Sales and Value (2012-2017)
        7.1.1 Southeast Asia Conjugate Vaccine Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Conjugate Vaccine Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Conjugate Vaccine Sales Price Trend (2012-2017)
    7.2 Southeast Asia Conjugate Vaccine Sales Volume and Market Share by Players
    7.3 Southeast Asia Conjugate Vaccine Sales Volume and Market Share by Type
    7.4 Southeast Asia Conjugate Vaccine Sales Volume and Market Share by Application

8 India Conjugate Vaccine (Volume, Value and Sales Price)
    8.1 India Conjugate Vaccine Sales and Value (2012-2017)
        8.1.1 India Conjugate Vaccine Sales and Growth Rate (2012-2017)
        8.1.2 India Conjugate Vaccine Revenue and Growth Rate (2012-2017)
        8.1.3 India Conjugate Vaccine Sales Price Trend (2012-2017)
    8.2 India Conjugate Vaccine Sales Volume and Market Share by Players
    8.3 India Conjugate Vaccine Sales Volume and Market Share by Type
    8.4 India Conjugate Vaccine Sales Volume and Market Share by Application

9 Global Conjugate Vaccine Players/Suppliers Profiles and Sales Data
    9.1 Bharat Biotech (India)
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Conjugate Vaccine Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Bharat Biotech (India) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Biological E (India)
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Conjugate Vaccine Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Biological E (India) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 CSL Limited (Australia)
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Conjugate Vaccine Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 CSL Limited (Australia) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 GlaxoSmithKline (U.K.)
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Conjugate Vaccine Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 GlaxoSmithKline (U.K.) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Merck and Company (U.S.)
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Conjugate Vaccine Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Merck and Company (U.S.) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Neuron Biotech (U.S.)
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Conjugate Vaccine Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Neuron Biotech (U.S.) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Novartis AG (Switzerland)
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Conjugate Vaccine Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Novartis AG (Switzerland) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Pfizer (U.S.)
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Conjugate Vaccine Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Pfizer (U.S.) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Sanofi Pasteur (France)
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Conjugate Vaccine Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Sanofi Pasteur (France) Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview

10 Conjugate Vaccine Maufacturing Cost Analysis
    10.1 Conjugate Vaccine Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Conjugate Vaccine
    10.3 Manufacturing Process Analysis of Conjugate Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Conjugate Vaccine Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Conjugate Vaccine Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Conjugate Vaccine Market Forecast (2017-2022)
    14.1 Global Conjugate Vaccine Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Conjugate Vaccine Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Conjugate Vaccine Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Conjugate Vaccine Price and Trend Forecast (2017-2022)
    14.2 Global Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Conjugate Vaccine Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Conjugate Vaccine Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Conjugate Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Conjugate Vaccine Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Conjugate Vaccine Sales Forecast by Type (2017-2022)
       14.3.2 Global Conjugate Vaccine Revenue Forecast by Type (2017-2022)
       14.3.3 Global Conjugate Vaccine Price Forecast by Type (2017-2022)
    14.4 Global Conjugate Vaccine Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer